Mallinckrodt said it will spin off its specialty generics business without the constipation treatment Amitiza and revise its plans for debt for the two resulting companies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,